Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, October 26, 2014 11:05:06 AM
bullish long term
$ACAD recent news/filings
## source: finance.yahoo.com
Fri, 12 Sep 2014 10:00:00 GMT ~ Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH
read full: http://www.thestreet.com/story/12850472/1/jim-cramers-top-stock-picks-twtr-tasr-acad-isis-rh.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Thu, 11 Sep 2014 22:43:27 GMT ~ Biotech targets: Cramer's quality candidates
read full: http://www.cnbc.com/id/101993382?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=101993382
*********************************************************
Thu, 11 Sep 2014 22:40:00 GMT ~ [video] Cramer: ACAD and ISIS have room to run
read full: http://video.cnbc.com/gallery/?video=3000309705&__source=yahoo%7cheadline%7cquote%7cvideo%7c&par=yahoo
*********************************************************
Sat, 06 Sep 2014 07:33:00 GMT ~ [$$] Charting the Market
read full: http://online.barrons.com/article/SB51885783724964273656104580132270969543704.html?mod=yahoobarrons&ru=yahoo
*********************************************************
Tue, 02 Sep 2014 18:38:00 GMT ~ Why ACADIA Pharmaceuticals (ACAD) Stock Is Spiking Today
read full: http://www.thestreet.com/story/12863505/1/why-acadia-pharmaceuticals-acad-stock-is-spiking-today.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$ACAD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ACAD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ACAD/company-info
Ticker: $ACAD
OTC Market Place: Not Available
CIK code: 0001070494
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
Incorporated In: DE, USA
$ACAD share structure
## source: otcmarkets.com
Market Value: $2,676,839,329 a/o Oct 24, 2014
Shares Outstanding: 99,436,825 a/o Jul 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$ACAD extra dd links
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ACAD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ACAD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ACAD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/news - http://finance.yahoo.com/q/h?s=ACAD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ACAD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ACAD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ACAD
DTCC (dtcc.com): http://search2.dtcc.com/?q=ACADIA+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ACADIA+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ACADIA+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.acadia-pharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.acadia-pharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.acadia-pharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ACAD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001070494&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ACAD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ACAD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ACAD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ACAD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ACAD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ACAD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ACAD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ACAD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ACAD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ACAD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ACAD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ACAD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ACAD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ACAD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ACAD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ACAD
$ACAD DD Notes ~ http://www.ddnotesmaker.com/ACAD
Recent ACAD News
- Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 • Business Wire • 04/24/2024 08:05:00 PM
- Acadia Pharmaceuticals annonce que la présentation de drogue nouvelle pour la trofinetide dans le traitement du syndrome de Rett a été acceptée pour dépôt et évaluation prioritaire par Santé Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/19/2024 08:05:00 PM
- Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting • Business Wire • 04/17/2024 08:05:00 PM
- Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development • Business Wire • 04/02/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/01/2024 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/15/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day • Business Wire • 03/13/2024 08:05:00 PM
- Oracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and More • IH Market News • 03/12/2024 11:21:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:55 PM
- Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia • Business Wire • 03/11/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 • Business Wire • 02/29/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:13:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:16:24 PM
- Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview • Business Wire • 02/27/2024 09:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/21/2024 09:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 12:08:13 PM
- Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 • Business Wire • 02/13/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:09:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:55:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM